NCT02208973
- Conditions
- Asthma, Bronchial Diseases, Chronic Disease, +11 more
- Locations
-
- CIM-Sant Pau - IIB Sant Pau, HSCSP Barcelona, Spain
- Palobiofarma S.L. (molecule owner) Mataró, Barcelona, Spain
Clinical trial condition
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
NCT02208973
NCT00017693
Not specified
NCT02302625
NCT02140086
NCT01704495
NCT02285049
NCT00005279
Not specified
NCT00628563
NCT00991874
Not specified
NCT01890148